Common genetic change found in some tumors of patients who relapse after aromatase inhibitor treatment

https://www.facingourrisk.org/XRAY/relapse-after-aromatase-inhibitor

Full article: https://www.nature.com/ng/journal/v49/n3/full/ng.3773.html

About one in five people diagnosed with estrogen receptor-positive (ER+) breast cancer relapse within 10 years after treatment. Researchers and health care providers do not know why this happens. This early research aims to identify a genetic change in the tumor that may cause relapse, but more studies are needed to understand why patients relapse and who is at risk. (5/3/17)

Questions To Ask Your Health Care Provider

What treatments are available for women with estrogen receptor-positive breast cancer?
How long should I remain on hormonal therapy?
What are the side effects of the treatment?
How will I know if my cancer has relapsed?

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.